The gut microbiome—the complex community of microorganisms in the gastrointestinal tract—profoundly influences dog health, immunity, and welfare. Understanding microbiome health enables more effective management of digestive conditions and overall wellbeing.
The canine gut microbiome comprises thousands of bacterial species that collectively perform essential functions: fermentation of dietary fibre producing short-chain fatty acids; immune system development and regulation; vitamin synthesis; pathogen exclusion through competitive exclusion and antimicrobial compound production; and modulation of the gut-brain axis affecting mood and behaviour. Disruption of microbiome balance (dysbiosis) is associated with inflammatory bowel disease, anxiety, skin disease, and metabolic conditions.
Diet is the primary determinant of microbiome composition. High dietary fibre supports diverse fermentative bacteria populations. Highly processed, low-fibre diets reduce microbiome diversity and short-chain fatty acid production. Raw meat diets create specific microbiome patterns with zoonotic risk implications. Prebiotic supplements (fructooligosaccharides, inulin) selectively stimulate beneficial bacteria growth. Dietary transitions should be gradual—abrupt changes cause dysbiosis and gastrointestinal upset.
Antibiotic treatment disrupts gut microbiome significantly—even short courses cause lasting compositional changes in some dogs. Antibiotic-associated diarrhoea reflects dysbiosis; Clostridium difficile overgrowth is an extreme manifestation. Concurrent probiotic use may reduce disruption severity. Microbiome recovery following antibiotic exposure takes weeks to months, during which vulnerability to digestive problems persists. Antibiotic stewardship—using the narrowest-spectrum antibiotic for the shortest effective duration—protects microbiome health.
Species-specific canine probiotics (Enterococcus faecium SF68, Lactobacillus acidophilus, Bifidobacterium species) can reduce antibiotic-associated diarrhoea, improve acute and chronic enteropathy outcomes, and support immune function. Faecal microbiota transplantation (FMT) from healthy donors is emerging as a treatment for severe dysbiosis. Synbiotic products combining probiotics and prebiotics provide combined microbiome support. The field is rapidly evolving—specific product selection should be based on current evidence.